Omega 3 and atrial fibrillation: Where are we?

doi:10.4330/wjc.v8.i2.114

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5694)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

444

WORD

328

HTML

2642

Figures (1-1)

Tables (1-4)

Sum=3414

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

828

Download

1452

Sum=2280

Feb 26, 2016 (publication date) through Jun 16, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Cardiol. Feb 26, 2016; 8(2): 114-119
Published online Feb 26, 2016. doi: 10.4330/wjc.v8.i2.114

Full Size Figure Download Figure

Figure 1 Antiarrhythmic effects of n-3 poly-unsaturated fatty acids. N-3 PUFA: N-3 poly-unsaturated fatty acids; TxA2: Thromboxane A2; PLC: Phospholipase C; IP3: Inositol triphosphate; AF: Atrial fibrillation.

Citation: Martino A, Pezzi L, Magnano R, Salustri E, Penco M, Calo’ L. Omega 3 and atrial fibrillation: Where are we? World J Cardiol 2016; 8(2): 114-119
URL: https://www.wjgnet.com//full/v8/i2/114.htm
DOI: https://dx.doi.org/10.4330/wjc.v8.i2.114